View in EDS HTML Full Text PDF Full Text

Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial.

Saved in:

Bibliographic Details
Title:	Switch to raltegravir decreases soluble CD14 in virologically suppressed overweight women: the Women, Integrase and Fat Accumulation Trial.
Authors:	Lake, JE¹, McComsey, GA², Hulgan, T³, Wanke, CA⁴, Mangili, A⁴, Walmsley, SL⁵, Stramotas, SA⁶, Tracy, R⁷, Currier, JS¹
Source:	HIV Medicine. Aug2014, Vol. 15 Issue 7, p431-441. 11p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!